ArticlePloS one2018

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.

Saman Maleki Vareki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.